http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CU-20110190-A7

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
filingDate 2011-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d460fb624d667dbd5981f427aea9fbef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2903d14715bb76555ffa94959412f1b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9cac3497a4e2454825781bf1f0b908a9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d746602ff33d5d1d164489b1d5f39608
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f0b7155e5ab6335c64f442a427671d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8829c00952903dc3011be00a2400fd2b
publicationDate 2012-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CU-20110190-A7
titleOfInvention ANALOGS OF ISOXAZOL-3 (2H) -ONA AS THERAPEUTIC AGENTS
abstract A compound of formula I SPACE FOR THE FORMULA or a pharmaceutically acceptable salt thereof, where R1 and R2 are independently hydrogen, deuterium, aryl, heteroaryl, C1-C8 alkyl, and are optionally substituted with one or more substituents that are independently R3, R3 is an aryl, heteroaryl, one or more fluorine atoms, a C1-C6 alkyl containing one or more fluorine atoms, a C1-C6 alkyl containing one or more deuterium atoms, a C1-C6 alkyl containing hydroxy , the aryl and heteroaryl being optionally substituted with one or more halogens, a fluorinated alkoxy, a fluorinated alkyl, a sulfonyl, one or more deuterium atoms, a C1-C6 alkyl, a C1-C6 alkoxy, a nitrile, or R3 it is a C1-C6 alkyl optionally substituted with one or more of the following groups: COOR4, OCOR4, CONR5R6, NR5COR6, OR4; wherein R4 is a C1-C10 alkyl optionally substituted with one or more fluorine, deuterium, alkoxy, aryl carboxylate, alkyl carboxylate atoms; R5 and R6 are independently selected from hydrogen, alkyl or can together form a 4-8 membered carbon ring; or R1 and R2 form a 3-10 membered carbon ring which optionally comprises O or N and is optionally substituted with a C1-C10 alkyl or aryl, heteroaryl optionally substituted with R3.
priorityDate 2009-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455581532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID167583

Total number of triples: 34.